{"id":"W4403725185","doi":"10.14309/01.ajg.0001033876.32560.38","title":"S1127 A Randomized, Double-Blind, Placebo-Controlled Trial of Vedolizumab With and Without Upadacitinib in Adults With Crohn’s Disease: Design and Rationale for the VICTRIVA Study","year":2024,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Western University","funders":"","keywords":"Vedolizumab; Medicine; Placebo; Crohn's disease; Double blind; Randomized controlled trial; Internal medicine; Disease; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008002725,0.003433565,0.005117056,0.0006884027,0.0008781207,0.00170697,0.00161363,0.004632165,0.01338878],"category_scores_gemma":[0.004640542,0.001459564,0.003342052,0.0006437878,0.002375245,0.001690365,0.0007532946,0.003978975,0.003324091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007717193,"about_ca_system_score_gemma":0.002279938,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004233769,"about_ca_topic_score_gemma":0.001045969,"domain_scores_codex":[0.9955438,0.002804175,0.0003091024,0.0006387833,0.0003162419,0.0003878563],"domain_scores_gemma":[0.9978276,0.0006744884,0.0003864201,0.0002646332,0.0002995328,0.0005472779],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9852071,0.005028217,0.000340063,0.0008606048,0.0008393755,0.00003541165,0.00003318973,0.000182881,0.002155502,0.0002847823,0.0007642853,0.004268507],"study_design_scores_gemma":[0.9620611,0.03559078,0.0003760501,0.00003727262,0.0003786518,0.00001232483,0.000008991684,0.0002034251,0.0001727264,0.0001839111,0.0009623611,0.00001230167],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.7131891,0.01107781,0.005345937,0.003239609,0.005044279,0.2445886,0.006211866,0.0003957443,0.01090705],"genre_scores_gemma":[0.7091684,0.003816007,0.0118874,0.005637504,0.002021276,0.2529105,0.003853913,0.00007397166,0.01063106],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.01338878,"threshold_uncertainty_score":0.04478997,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01045842773962506,"score_gpt":0.2636134327755028,"score_spread":0.2531550050358777,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}